Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
Harnessing artificial intelligence and machine learning to combat fraud: A new era in investigations
While the sophistication of fraud and financial crimes continues to grow, advancements in artificial intelligence (AI) and machine learning (ML) have...